Invesco Ltd. Royalty Pharma PLC Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Invesco Ltd. holds 1,284,418 shares of RPRX stock, worth $46.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,284,418

Previous 957,893 34.09%

Holding current value

$46.1 Million

Previous $24.4 Million 63.63%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$25.75 - $33.86 $8.41 Million - $11.1 Million	326,525 Added 34.09%	1,284,418 $40 Million
Q4 2024 Feb 13, 2025	BUY	$24.28 - $28.39 $5.79 Million - $6.77 Million	238,508 Added 33.15%	957,893 $24.4 Million
Q3 2024 Nov 12, 2024	SELL	$25.63 - $29.27 $26.1 Million - $29.8 Million	-1,017,136 Reduced 58.57%	719,385 $20.4 Million
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $27.9 Million - $31.8 Million	1,062,833 Added 157.76%	1,736,521 $45.8 Million
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $462,234 - $527,377	16,833 Added 2.56%	673,688 $20.5 Million
Q4 2023 Feb 12, 2024	BUY	$26.21 - $29.22 $1.23 Million - $1.37 Million	46,849 Added 7.68%	656,855 $18.5 Million
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $2.1 Million - $2.51 Million	-79,942 Reduced 11.59%	610,006 $16.6 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $687,282 - $848,886	-23,219 Reduced 3.26%	689,948 $21.2 Million
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $71.1 Million - $85.5 Million	-2,169,823 Reduced 75.26%	713,167 $25.7 Million
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $9.71 Million - $10.9 Million	-247,861 Reduced 7.92%	2,882,990 $114 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $19.1 Million - $21.4 Million	479,358 Added 18.08%	3,130,851 $126 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $73.9 Million - $87 Million	1,968,126 Added 288.0%	2,651,493 $111 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $5.24 Million - $5.93 Million	139,768 Added 25.71%	683,367 $26.6 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $2.98 Million - $3.59 Million	-84,611 Reduced 13.47%	543,599 $21.7 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $2.36 Million - $2.76 Million	-65,308 Reduced 9.42%	628,210 $22.7 Million
Q2 2021 Aug 17, 2021	BUY	$39.85 - $46.63 $1.23 Million - $1.44 Million	30,885 Added 4.66%	693,518 $28.4 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $19.1 Million - $23.9 Million	451,898 Added 214.44%	662,633 $28.9 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $22.4 Million - $31.1 Million	-621,386 Reduced 74.67%	210,735 $10.5 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $3.17 Million - $3.97 Million	82,121 Added 10.95%	832,121 $35 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $33.4 Million - $39.1 Million	750,000 New	750,000 $36.4 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account